{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:20:57Z","timestamp":1783776057749,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11060-015-2012-x","type":"journal-article","created":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T04:55:49Z","timestamp":1449464149000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells"],"prefix":"10.1007","volume":"127","author":[{"given":"Johnathan E.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert J.","family":"Belton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"issue":"Suppl 4","key":"2012_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2007\u20132011. Neuro-oncology 16(Suppl 4):iv1\u2013iv63. doi: 10.1093\/neuonc\/nou223","journal-title":"Neuro-oncology"},{"key":"2012_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11910-014-0517-x","volume":"15","author":"JP Almeida","year":"2015","unstructured":"Almeida JP, Chaichana KL, Rincon-Torroella J, Quinones-Hinojosa A (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15:517. doi: 10.1007\/s11910-014-0517-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2012_CR3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0021-9258(18)64861-6","volume":"225","author":"E Schiffmann","year":"1957","unstructured":"Schiffmann E, Shemin D (1957) Further studies on the utilization of delta-aminolevulinic acid for porphyrin synthesis. J Biol Chem 225:623\u2013628","journal-title":"J Biol Chem"},{"key":"2012_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/00006123-199803000-00017","volume":"42","author":"W Stummer","year":"1998","unstructured":"Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518\u2013525 (discussion 525\u2013516)","journal-title":"Neurosurgery"},{"key":"2012_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401. doi: 10.1016\/S1470-2045(06)70665-9","journal-title":"Lancet Oncol"},{"key":"2012_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11060-010-0296-4","volume":"102","author":"R Diez Valle","year":"2011","unstructured":"Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105\u2013113. doi: 10.1007\/s11060-010-0296-4","journal-title":"J Neurooncol"},{"key":"2012_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00701-013-1660-x","volume":"155","author":"A Della Puppa","year":"2013","unstructured":"Della Puppa A, De Pellegrin S, d\u2019Avella E, Gioffre G, Rossetto M, Gerardi A, Lombardi G, Manara R, Munari M, Saladini M, Scienza R (2013) 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature. Acta Neurochir 155:965\u2013972. doi: 10.1007\/s00701-013-1660-x (discussion 972)","journal-title":"Acta Neurochir"},{"key":"2012_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1227\/NEU.0b013e31826d1e6b","volume":"71","author":"P Schucht","year":"2012","unstructured":"Schucht P, Beck J, Abu-Isa J, Andereggen L, Murek M, Seidel K, Stieglitz L, Raabe A (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurgery 71:927\u2013935. doi: 10.1227\/NEU.0b013e31826d1e6b (discussion 935\u2013926)","journal-title":"Neurosurgery"},{"key":"2012_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00701-013-1906-7","volume":"156","author":"P Schucht","year":"2014","unstructured":"Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J (2014) 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir 156:305\u2013312. doi: 10.1007\/s00701-013-1906-7 (discussion 312)","journal-title":"Acta Neurochir"},{"key":"2012_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00701-012-1290-8","volume":"154","author":"G Campe von","year":"2012","unstructured":"von Campe G, Moschopulos M, Hefti M (2012) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir (Wien) 154:585\u2013588","journal-title":"Acta Neurochir (Wien)"},{"key":"2012_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4236\/ijcm.2012.32026","volume":"3","author":"S Utsuki","year":"2012","unstructured":"Utsuki S, Oka H, Kijima C, Inukai M, Fujii K, Ishizuka M, Takahashi K, Inoue K (2012) Preoperative prediction of whether intraoperative fluorescence of protoporphyrin IX can be achieved by 5-aminolevulinic acid administration. Int J Clin Med 3:132","journal-title":"Int J Clin Med"},{"key":"2012_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2133\/dmpk.22.428","volume":"22","author":"A Tamura","year":"2007","unstructured":"Tamura A, Onishi Y, An R, Koshiba S, Wakabayashi K, Hoshijima K, Priebe W, Yoshida T, Kometani S, Matsubara T, Mikuriya K, Ishikawa T (2007) In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab Pharmacokinet 22:428\u2013440","journal-title":"Drug Metab Pharmacokinet"},{"key":"2012_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00432-009-0578-4","volume":"135","author":"Y Jin","year":"2009","unstructured":"Jin Y, Bin ZQ, Qiang H, Liang C, Hua C, Jun D, Dong WA, Qing L (2009) ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma. J Cancer Res Clin Oncol 135:1369\u20131376","journal-title":"J Cancer Res Clin Oncol"},{"key":"2012_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/bjc.2011.12","volume":"104","author":"L Teng","year":"2011","unstructured":"Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y, Hamada JI (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 104:798\u2013807. doi: 10.1038\/bjc.2011.12","journal-title":"Br J Cancer"},{"key":"2012_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11060-012-0857-9","volume":"108","author":"M Hefti","year":"2012","unstructured":"Hefti M, Albert I, Luginbuehl V (2012) Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells. J Neurooncol 108:443\u2013450. doi: 10.1007\/s11060-012-0857-9","journal-title":"J Neurooncol"},{"key":"2012_CR16","doi-asserted-by":"publisher","first-page":"405360","DOI":"10.1155\/2014\/405360","volume":"2014","author":"JE Lawrence","year":"2014","unstructured":"Lawrence JE, Patel AS, Rovin RA, Belton RJ Jr, Bammert CE, Steele CJ, Winn RJ (2014) Quantification of protoporphyrin IX accumulation in glioblastoma cells: a new technique. ISRN Surg 2014:405360. doi: 10.1155\/2014\/405360","journal-title":"ISRN Surg"},{"key":"2012_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/00912700122010285","volume":"41","author":"G Hochhaus","year":"2001","unstructured":"Hochhaus G, Barth J, al-Fayoumi S, Suarez S, Derendorf H, Hochhaus R, Mollmann H (2001) Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP). J Clin Pharmacol 41:425\u2013434","journal-title":"J Clin Pharmacol"},{"key":"2012_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/FTD.0b013e318157032d","volume":"29","author":"F Lancelin","year":"2007","unstructured":"Lancelin F, Franchon E, Kraoul L, Garciau I, Brovedani S, Tabaouti K, Landre E, Chassoux F, Paubel P, Piketty ML (2007) Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy. Ther Drug Monit 29:576\u2013583. doi: 10.1097\/FTD.0b013e318157032d","journal-title":"Ther Drug Monit"},{"key":"2012_CR19","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/neuonc\/nov049","volume":"12","author":"B Schatlo","year":"2015","unstructured":"Schatlo B, Fandino J, Smoll NR, Wetzel O, Remonda L, Marbacher S, Perrig W, Landolt H, Fathi A-R (2015) Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery. Neuro-oncology\u00a012:1560\u20131567. doi: 10.1093\/neuonc\/nov049","journal-title":"Neuro-oncology"},{"key":"2012_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.202","author":"AJ Awad","year":"2014","unstructured":"Awad AJ, Sloan A (2014) The use of 5-ALA in glioblastoma resection: two cases with long-term progression-free survival. Cureus. doi: 10.7759\/cureus.202","journal-title":"Cureus"},{"key":"2012_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejso.2013.11.022","volume":"40","author":"C Roder","year":"2014","unstructured":"Roder C, Bisdas S, Ebner FH, Honegger J, Naegele T, Ernemann U, Tatagiba M (2014) Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Eur J Surg Oncol 40:297\u2013304. doi: 10.1016\/j.ejso.2013.11.022","journal-title":"Eur J Surg Oncol"},{"key":"2012_CR22","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","volume":"67","author":"M Veiseh","year":"2007","unstructured":"Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ, Kwok D, Munoz NM, Sze RW, Grady WM, Greenberg NM, Ellenbogen RG, Olson JM (2007) Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67:6882\u20136888. doi: 10.1158\/0008-5472.CAN-06-3948","journal-title":"Cancer Res"},{"key":"2012_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/02688690701765524","volume":"22","author":"K Koc","year":"2008","unstructured":"Koc K, Anik I, Cabuk B, Ceylan S (2008) Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg 22:99\u2013103. doi: 10.1080\/02688690701765524","journal-title":"Br J Neurosurg"},{"key":"2012_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejso.2014.07.044","volume":"41","author":"P Schucht","year":"2015","unstructured":"Schucht P, Beck J, Raabe A (2015) Response to: \u201cMaximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery\u201d. Eur J Surg Oncol 41:604\u2013605. doi: 10.1016\/j.ejso.2014.07.044","journal-title":"Eur J Surg Oncol"},{"key":"2012_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00701-015-2401-0","volume":"157","author":"M Schwake","year":"2015","unstructured":"Schwake M, Stummer W, Suero Molina EJ, Wolfer J (2015) Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery. Acta Neurochir (Wien) 157:877\u2013879. doi: 10.1007\/s00701-015-2401-0","journal-title":"Acta Neurochir (Wien)"},{"key":"2012_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clineuro.2015.01.005","volume":"130","author":"S Yamada","year":"2015","unstructured":"Yamada S, Muragaki Y, Maruyama T, Komori T, Okada Y (2015) Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas. Clin Neurol Neurosurg 130:134\u2013139. doi: 10.1016\/j.clineuro.2015.01.005","journal-title":"Clin Neurol Neurosurg"},{"key":"2012_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-007-9497-x","volume":"87","author":"W Stummer","year":"2008","unstructured":"Stummer W, Beck T, Beyer W, Mehrkens JH, Obermeier A, Etminan N, Stepp H, Tonn JC, Baumgartner R, Herms J, Kreth FW (2008) Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol 87:103\u2013109. doi: 10.1007\/s11060-007-9497-x","journal-title":"J Neurooncol"},{"key":"2012_CR28","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O","volume":"79","author":"Q Peng","year":"1997","unstructured":"Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79:2282\u20132308","journal-title":"Cancer"},{"key":"2012_CR29","doi-asserted-by":"crossref","unstructured":"Kim JE, Cho HR, Xu WJ, Kim JY, Kim SK, Kim SK, Park SH, Kim H, Lee SH, Choi SH, Park S, Park CK (2015) Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas. Oncotarget","DOI":"10.18632\/oncotarget.4060"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-2012-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2012-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T13:00:35Z","timestamp":1653742835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-2012-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-2012-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]},"assertion":[{"value":"4 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}